Joan Merrill to Clinical Trials as Topic
This is a "connection" page, showing publications Joan Merrill has written about Clinical Trials as Topic.
Connection Strength
1.402
-
Why, why, why de-lupus (does so badly in clinical trials). Expert Rev Clin Immunol. 2016; 12(2):95-8.
Score: 0.474
-
Clinical trials for lupus--are we there yet? Bull NYU Hosp Jt Dis. 2009; 67(3):267-70.
Score: 0.291
-
New Trials in Lupus and where Are we Going. Curr Rheumatol Rep. 2018 05 03; 20(6):34.
Score: 0.139
-
Co-stimulatory molecules as targets for treatment of lupus. Clin Immunol. 2013 Sep; 148(3):369-75.
Score: 0.098
-
Clinical trials in lupus: what have we learned so far? Rheumatology (Oxford). 2010 Jun; 49(6):1025-7.
Score: 0.078
-
Is individualized medicine on the horizon for lupus? Curr Rheumatol Rep. 2008 Aug; 10(4):257-8.
Score: 0.071
-
A lupus drug and FDA approval. Science. 2005 Apr 22; 308(5721):497; author reply 497.
Score: 0.056
-
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosus. J Am Acad Dermatol. 2021 Jun; 84(6):1562-1567.
Score: 0.040
-
Clinical trials for the antiphospholipid syndrome. Curr Rheumatol Rep. 2000 Jun; 2(3):233-7.
Score: 0.040
-
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Sci Med. 2020; 7(1):e000360.
Score: 0.039
-
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Rheumatology (Oxford). 2018 01 01; 57(1):125-133.
Score: 0.034
-
The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. 2011 Mar; 70 Suppl 1:i37-43.
Score: 0.021
-
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 2011 Mar; 20(3):250-5.
Score: 0.021